HIV-1 Nef impairs MHC class II antigen presentation and surface expression

Area of Science:

• Immunology
• Virology
• Molecular Biology

Background:

• Human Immunodeficiency Virus type 1 (HIV-1) infected cells evade immune detection.
• The Nef protein of HIV-1 is known to down-regulate MHC class I (MHC I) expression.
• MHC I down-regulation helps infected cells escape cytotoxic T lymphocyte (CTL) killing.

Purpose of the Study:

• To investigate the effect of HIV-1 Nef on MHC class II (MHC II) restricted peptide presentation.
• To determine if Nef influences the induction of antiviral immune responses via MHC II.
• To elucidate the mechanism by which Nef affects MHC II function.

Main Methods:

• Assessing the impact of HIV-1 Nef on surface levels of mature and immature MHC II.
• Evaluating Nef's effect on MHC II restricted peptide presentation to T cells.
• Analyzing the influence of the entire HIV-1 genome and specific Nef mutations on MHC II.

Main Results:

• HIV-1 Nef inhibits MHC II restricted peptide presentation, potentially impairing antiviral immunity.
• Nef reduces surface levels of mature MHC II while increasing immature MHC II, which are non-functional.
• Nef was the sole HIV-1 protein with this MHC II inhibitory capacity, observed even with the full HIV-1 genome.
• Nef's effects on MHC II did not stem from general endocytic pathway alterations.
• Distinct Nef mutations and required doses suggested separate mechanisms for modulating mature and immature MHC II.

Conclusions:

• HIV-1 Nef actively inhibits MHC II peptide presentation, contributing to immune evasion.
• Nef employs distinct mechanisms to reduce functional MHC II and increase non-functional forms.
• These cooperative mechanisms allow Nef to efficiently suppress MHC II function and antiviral immune responses.